Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in Korean population
Chinese Medical Journal, 02/22/2012
Doo-Yeoun C et al. - The present study demonstrated that high-sensitivity C-reactive protein (hs-CRP) and homocysteine are well associated with the 10-year coronary artery disease (CAD) risk estimated using NCEP ATP III in Koreans and combination of hs-CRP and homocysteine can have strong synergy in predicting the development of CAD.
A total of 10 650 subjects (6538 men and 4112 women) were enrolled in this study.
A 10-year CAD risk was calculated using Framingham risk score modified by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) and levels of circulating hs-CRP, homocysteine and fibrinogen were measured using validated assays.
The 10-year CAD risk gradually augmented with increase in the circulating levels of hs-CRP, homocysteine and fibrinogen.
For the highest quartile of hs-CRP, odds ratio (OR) of high-risk for CAD (10-year risk ≥20%) compared with the lowest quartile was 3.97 (95% CI: 2.51–6.29).
For homocysteine and fibrinogen, ORs in the highest quartile compared to the lowest quartile were 5.10 (95% CI: 3.05–8.53, P <0.001) and 1.46 (95% CI: 0.69–3.11, P=0.325), respectively.
OR of high-risk for CAD in both the highest quartile of hs-CRP and homocysteine was 9.05 (95% CI: 5.30–15.45) compared with the below median of hs-CRP and homocysteine.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.